 This study found that sodium selenate treatment can reduce the number of seizures, improve cognition, and reverse telomere shortening in chronically epileptic rats. Additionally, this treatment also resulted in increased pp2a expression, decreased hypophosphorili tel, and reversed telomere length shortening. These findings suggest that sodium selenate may be a promising therapeutic option for patients suffering from drug-resistant temporal lobe epilepsy. This article was authored by Pablo M. Casalisa Spinoza, Allison Anderson, Anna Haritinyan, and others.